A simple model of mortality trends aiming at universality: Lee Carter +
  Cohort by Debonneuil, Edouard
A simple model of mortality trends aiming at universality: Lee Carter + Cohort 
Edouard Debonneuil – AXA Cessions, Paris, France 
 
Summary The Lee Carter modelling framework is widely used because of its simplicity and 
robustness despite its inability to model specific cohort effects. A large number of extensions have 
been proposed that model cohort effects but there is no consensus. It is difficult to simultaneously 
account for cohort effects and age-adjusted improvements and we here test a simple model that 
accounts for both: we simply add a non age-adjusted cohort component to the Lee Carter 
framework. This is a trade-off between accuracy and robustness but, for various countries present in 
the Human Mortality Database and compared to various models, the model accurately fits past 
mortality data and gives good backtesting projections. 
  
Introduction 
The modelling and forecasting of mortality trends has received considerable attention since the 
development of a simple stochastic model by Lee and Carter (1992). This model - that models the log 
of the force of mortality by an age component plus an age-adjusted period component plus a 
gaussian error - has been improved in various ways such as by improving the modelling of the error 
term (Brouhns et al., 2002) or by adding cohort components. 
There is no consensus on how to model cohort effects. A good starting point to studying them is the 
toolkit Lifemetrics (Coughlan et al., 2007), that implements various models that have then been 
analyzed in details (Cairns et al, 2007, 2008). In particular the model 1 – the one with the Lee Carter 
parametric structure - is robust but does not account for cohort specificities. The model 2 - that adds 
an age-adjusted cohort component (Renshaw and Haberman, 2006) - has a tendency towards over 
fitting and associated lack of robustness. The model 3 – model 2 without age adjustments of period 
and cohort components (Currie et al., 2006) – is robust but does not account of age-specific mortality 
improvements. 
This article describes a model that is a trade-off between model 2 and model 3, in the aim to be as 
universal as possible. It models the log of the force of mortality by an age component plus an age-
adjusted period component plus a non age-adjusted cohort effect: it can be viewed as a Lee Carter 
model plus a simple cohort component or as a constrained Renshaw Haberman model. One 
application of such a model could be to fit many cases: it adapts to some age-specific improvements 
and to some cohort effects, but due to its limited number of parameters it should limit the risk of 
over fitting. 
To empirically test this degree of universality we will test it on mortality trends of various countries, 
using historical mortality data from general populations (Human Mortality Database). 
  
The LCC model: Lee Carter + Cohort 
Definition 
Using the notations of lifemetrics, figure 1 describes the new model (that we will name M9, or LCC) 
along with the models already presented in Lifemetrics. To be uniquely defined, constraints must be 
added: similarly to the models described in Lifemetrics we will require βx
(2) to sum to 1, κt
(2) to sum to 
0 and γt-x
(3) to sum to 0. It was implemented as a straightforward derivation of the implementation 
for the M2 model: βx
(3) is simply set to 1 and not fitted. 
 
Figure 1. Lifemetrics models and the Lee Carter+Cohort model (M9) 
Fitting 
The parameters β κ γ are fitted by maximum likelihood. The Bayesian Information Criterion (BIC) 
metric can be used to estimate whether a model fits data well: that indicator takes into account the 
fact that a model with many parameters has more chances to fit a set of data by chance. Table 1 
provides the obtained BIC when fitting historical deaths and exposures of various countries for males 
and females aged 40 to 95 year old between 1955 and 1980. M9 fits well as it leads to high BIC: 
Country, gender   M1    M2    M3    M5    M6    M7    M8 |   M9 
UK Male -10714 -9182 -9215 -24645 -9808 -9202 -9266 |-9014 
UK Female -9574 -9198 -9450 -19336 -11182 -9788 -9846 |-9069 
US Male -13844 -11491 -12951 -27286 -19093 -14818 -15964 |-11602 
US Female -14115 -11163 -12648 -65996 -16634 -16547 -16032 |-11415 
France Male -10811 -9080 -8992 -14256 -10148 -9166 -9538 |-8943 
France Female -9147 -8992 -9010 -42131 -13648 -11080 -10761 |-8846 
Switz. Male -6773 -7092 -6806 -6541 -6715 -6775 -6700 |-6935 
Switz. Female -6743 -7060 -6772 -8230 -6977 -6877 -6774 |-6923 
Spain Male -9058 -8538 -9145 -11237 -10595 -10183 -10041 |-8509 
Spain Female -9103 -8561 -9809 -22162 -15948 -12517 -13131 |-8533 
Japan Male -11465 -9249 -9274 -17559 -9656 -8851 -9242 |-9096 
Japan Female -11374 -9194 -9536 -38082 -14092 -10754 -10750 |-9140 
Table 1: on average M9 has a better BIC fitting indicator than M1, M2, M3, M5, M6, M7 and M8. For 
each country the best BIC value is set in bold. 
The UK as an example 
Here are a few examples to visually describe some limits of the models: 
- Cohort effect: as shown by the γt-x
(3) curves in figure 2a there is clearly a strong cohort effect in the 
UK for people born around 1920 (the curves for women are very similar; data not shown). The Lee 
Carter framework (M1) does not account for it; this is probably why M1 instead provides a βx
(2) that is 
very surprising, much less likely than the βx
(2) provided by M2 or M9, as shown in figure 2b. 
 
- Age-adjusted mortality improvements: the latter βx
(2) provided by M2 and M9 suggest that 
improvements mostly affect older ages; M3 cannot account for it because βx
(2)=1 for M3 
 
- Overfitting in the more complex model M2: No obvious overfitting was found for the UK for dates 
between 1955 and 1980 but some is found for dates between 1981 and 2006 for females, as shown 
in blue in figure 2c: the very perturbated βx
(2) and βx
(3) probably compensate each other to fit the data 
as much as possible, but those shapes are clearly artifacts (they would suggests much higher 
mortality improvements for age 47 than for age 46). 
 
a b c  
Figure 2: a) cohort effect (γt-x
(3)) fitted by M2, M3 and M9 for males: UK has a clear cohort effect. b) 
age-distribution of mortality improvements (βx
(2)) provided by M1, M2 and M9 for males: M1 
provides improbable shapes. c) βx
(2) and βx
(3) provided by M2 in the case of females aged 40 to 95 and 
between 1981 and 2006: there is a clear overfitting. 
 
Projections of M1, M2, M3 and M9 
The projection of models M1, M2, M3 and M9 requires extrapolating κt
(2) after 1980. There are many 
manners to do so. Rather than choosing a specific manner we computed what κt
(2) should be, to 
match mortality rates between 1981 and 2006 as much as possible: the parameters that were 
previously fitted (βx
(1), βx
(2), βx
(3) and γt-x
(3) for each model, country and gender between 1955 and 
1980) are reused between 1981 and 2006 except κt
(2) that is then fitted by maximum likelihood to 
match mortality rates between 1981 and 2006 (restricted to cohorts that were present in the data 
between 1955 and 1980). Figure 3 shows the corresponding κt
(2) along with linear extrapolation of 
past κt
(2) (norm 1 in red, norm 2 in green, norm infinite in grey). 
 
Figure 3. Fitted κt
(2) and goodness of projection. 
 
 
Discussion and conclusion 
Not all models predicted correctly all cases. All countries and times are specific. The UK is particular 
for its 1920-born short-lived cohort. Switzerland data is particular for its young-age-only mortality 
improvements, etc. Model M9 seems to fit mortality data quite well: it can be viewed as a trade-off 
between accuracy and robustness. Concerning projections, linear projections of κt
(2) do not seem to 
be the best solution in all cases but it seems difficult to have a better choice without referring to 
some expert judgement. Model M9 is arguably better in terms of projections. For a given country it 
shows similar evolutions of κt
(2) for males and females, which suggests that it captures the mortality 
trends of countries, even if those trends are difficult to model in a generic manner. 
It is difficult to expect much better as the discussed models do not take into account the background 
such as biomedical improvements and prevention knowledge that lead to longer lives. For example 
the slowdown of mortality improvements in Japan could be a reality due to a partial westernization 
of the Japanese society, and this westernization cannot be predicted by blind mathematical models. 
It is therefore in the absence of such contextual modelling that we suggest the choice of the Lee 
Carter + Cohort model for “acontextual” mortality trend modelling. 
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